Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 19, 2016Direct-to-Consumer Digital Marketing Strategy Driving Rapid Initial Market Penetration
LabStyle Innovations (NASDAQ: DRIO) - a leader in digital health and mobile health solutions and the developer of the Dario™ Smart Diabetes Management Solution - today announced that since the...
-
Jul 11, 2016Dario Smart Diabetes Management Solution to reach thousands of college students across the U.S.
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced it has joined the College Diabetes Network (CDN) as a Corporate Member. Since its...
-
May 27, 2016
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that the Company's Chief Financial Officer, Zvi Ben-David will present at the Marcum...
-
May 11, 201684% increase in sequential quarterly revenues
Quarterly gross loss narrowed 61% compared to Q4 2015 Net loss narrowed by 29% compared to Q4 2015 Launched Dario Blood Glucose Monitoring System in the United States late in the first quarter...
-
May 5, 2016
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that it has been granted a key patent by the European Patent Office (EPO) for the...
-
Mar 23, 2016
ADVISORY, March 23, 2016 (GLOBE NEWSWIRE) -- What: LabStyle Innovations Corp. (Nasdaq:DRIO), developer of the Dario™ Blood Glucose Monitoring System, will visit the Nasdaq MarketSite in Times...
-
Mar 15, 2016World's largest glucose monitoring market gets user-centric mHealth product that brings diabetes management into the digital age
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the national availability of Dario in the U.S. The U.S. rollout follows the...
-
Mar 9, 2016Broadens platform technology's applications beyond mHealth and into health and non-health related industrial markets
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the U.S. Patent and Trademark Office has issued the Company patent #9257038...
-
Mar 4, 2016Company Effects a 1-for-18 Reverse Stock Split
LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective...
-
Feb 9, 2016- FDA clearance announced on December 22nd
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, reported financial and operational results for the year ended December 31, 2015 and provided an...